SI-BONE Reports Strong Q4 & FY25 Results, Achieves Profitability Milestones, and Issues Positive 2026 Guidance
summarizeSummary
SI-BONE, Inc. announced robust fourth quarter and full-year 2025 financial results, highlighted by significant revenue growth, improved profitability, and positive free cash flow, alongside optimistic 2026 guidance and key operational advancements.
check_boxKey Events
-
Strong Q4 and Full-Year 2025 Financial Performance
Reported worldwide revenue growth of 15.0% for Q4 and 20.2% for the full year 2025, reaching $200.9 million. The company significantly improved profitability, achieving positive adjusted EBITDA of $5.1 million in Q4 and $8.9 million for the full year, alongside positive free cash flow in Q4.
-
Positive 2026 Financial Guidance
Issued 2026 worldwide revenue guidance in the range of $228.5 million to $232.5 million, implying 14% to 16% year-over-year growth, and expects increased positive adjusted EBITDA.
-
Strategic Partnership and Product Expansion
Entered a strategic partnership with Smith+Nephew for iFuse TORQ distribution in trauma centers and launched INTRA Ti, expanding its SI joint fusion solutions.
-
Key Executive Promotion
Anshul Maheshwari, the Chief Financial Officer, was also appointed Chief Operating Officer, effective February 22, 2026, consolidating leadership roles.
auto_awesomeAnalysis
This 8-K details SI-BONE's strong financial performance for Q4 and full-year 2025, exceeding expectations with 20.2% worldwide revenue growth for the year and achieving positive adjusted EBITDA and positive free cash flow in Q4. The company also provided positive 2026 guidance, projecting continued revenue growth and increased profitability. These results demonstrate the company's successful execution and scalability, significantly improving its financial health and outlook. Additionally, the company announced a strategic partnership with Smith+Nephew and the promotion of its CFO to also serve as COO, signaling operational expansion and confidence in leadership. The new long-term lease supports the company's growth trajectory. Investors should view these developments as a strong indicator of the company's operational momentum and financial stability.
At the time of this filing, SIBN was trading at $16.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $677.8M. The 52-week trading range was $12.50 to $21.89. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.